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Introduction
Differences have been seen among the anti-TNFs in
mediating reverse signalling of membrane TNF-a
(mTNF-a). Natural killer (NK) cells express high levels
of mTNF-a and may be involved in rheumatoid arthritis
pathogenesis. We examined the effect of certolizumab
pegol (CZP) and the other anti-TNFs, adalimumab
(ADA), etanercept (ETA) and infliximab (IFX), on cellu-
lar activities of NK cells.
Methods
Peripheral blood mononuclear cells from healthy volun-
teers were isolated and incubated in the presence of
100 U/mL recombinant human (rh) interleukin-2 (IL-2)
for 20 h and 10 μg/mL anti-TNF agents or isotypic con-
trols (human IgG1k and Fab′ PEG) for a further 4 h. Anti-
body-dependent cellular cytotoxicity (ADCC) was
measured by loss of cell membrane integrity, by binding of
7-amino-actinomycin D to DNA. For analysis of soluble
cytokine production and b-hexosaminidase release as an
index of cell degranulation, NK cells were incubated with
rhIL-2 and anti-TNF agents. The concentration of the
soluble cytokine interferon-g (IFN-g) was determined by
enzyme-linked immunosorbent assay. b-hexosaminidase
release was quantified upon enzymatic cleavage of 4-
methylumbelliferyl N-acetyl-b-D-glucosaminide in citrate
buffer (0.1 M, pH 4.5) by spectrophotometric analysis.
Results
When NK cells were incubated with anti-TNF agents in
the presence of rhIL-2, IFN-g production was signifi-
cantly increased from the control level of ~84 pg/mL to
~1.1 ng/mL. All 4 anti-TNF agents stimulated NK cell
degranulation, as measured by b-hexosaminidase levels,
to a level of ~27% degranulation compared with a con-
trol level of 3%. ADCC measured in NK cells was
detectable only with ADA, ETA and IFX (44.3%, 46.4%
and 47.9%, respectively) and not with CZP (1%).
Conclusion
Anti-TNF agents may result in increased NK cell–
mediated cytotoxicity by promoting the release of multi-
ple cytotoxic effector molecules and inflammatory cyto-
kines via reverse signalling through constitutively
expressed mTNF-a. CZP can activate NK cells but, in
contrast to conventional anti-TNFs, does not mediate
ADCC due to its unique structure (lacking an Fc
region).
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